EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of 5T33MM bearing mice with recombinant Fc-OPG results in decreased tumor burden and increased survival



Treatment of 5T33MM bearing mice with recombinant Fc-OPG results in decreased tumor burden and increased survival



Clinical & Experimental Metastasis 19(Supplement): 52




(PDF 0-2 workdays service: $29.90)

Accession: 035980307

Download citation: RISBibTeXText



Related references

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival. Journal of Bone and Mineral Research 18(3): 482-492, 2003

Irradiation plus intraperitoneal delivery of iododeoxyuridine results in increased survival of mice bearing an ascites tumor. Proceedings of the American Association for Cancer Research Annual Meeting 40: 147, March, 1999

Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical Cancer Research 3(4): 605-611, 1997

Increased myo fibrillar degradation and decreased protein synthesis in tumor bearing mice. European Journal Of Clinical Investigationpart 2: 10, 1982

Increased survival of tumor-bearing mice by the delta opioid SNC 80. Anticancer Research 25(6c): 4563-4567, 2005

Decreased survival of tumor bearing mice following in vivo administration of anti murine interferon gamma monoclonal antibodies. Proceedings of the American Association for Cancer Research Annual Meeting 29: 369, 1988

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Research 53(9): 2087-2091, 1993

Anti-tumor effect of recombinant OPG in the murine 5T33MM model. Blood 98(11 Part 1): 637a, November 16, 2001

Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. Oral Oncology 50(2): 104-112, 2014

Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. American Journal of Pathology 169(6): 2181-2198, 2006

Effects of combined cyclo phosphamide and thymosin treatment on tumor growth and host survival in mice bearing a syngeneic tumor. Goldstein, A L And M A Chirigos (Ed ) Progress in Cancer Research And Therapy, Vol 20 Lymphokines And Thymic Hormones: Their Potential Utilization in Cancer Therapeutics Xviii+324p Raven Press: New York, N Y , Usa Illus P249-256, 1981

Chelerythrine delayed tumor growth and increased survival duration of Dalton's lymphoma bearing BALB/c H(2d) mice by activation of NK cells in vivo. Journal of Cancer Research and Therapeutics 11(4): 904-910, 2016

Prolonged survival of male-to-female skin isografts and of allografts from normal mice following treatment of recipient or graft with sera from tumor-bearing mice. Cancer Research 31(2): 122-126, 1971

Increased production of tumor necrosis factor in endotoxin induced shock in mice pretreated with sera of tumor bearing mice or with factors produced by tumor cells in vitro. Byulleten' Eksperimental'noi Biologii i Meditsiny 112(7): 78-80, 1991

Increased survival in tumor bearing mice receiving intravenous syngeneic bone marrow cells preincubated in lf 1695 5 amino 2 4 methyl 1 piperidinylphenyl 4 chlorophenylmethanone. International Journal of Immunopharmacology 7(3): 315, 1985